• Français
  • Search
  • Conference
    • CAHR 2021 Virtual
    • Future CAHR Conferences
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • UWW E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • Become a Member
    • CAHR Annual General Meeting
    • CAHR Strategic Plan 2020 – 2025
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media
    • Featured Researchers
  • Conference
    • CAHR 2021 Virtual
    • Sponsors & Exhibitors
    • Future CAHR Conferences
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • UWW E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • Become a Member
    • CAHR Strategic Plan 2020 – 2025
    • CAHR Annual General Meeting
    • Call for Nominations: CAHR Board of Directors
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media
    • Featured Researchers

Dr. Michel J. Tremblay

Host Targets of HIV

HIV is a tricky virus; it hijacks cells of the immune system, uses their machinery, spreads to other cells and evades the immune system to persist in the host indefinitely. Development of effective treatments for HIV requires multifaceted research to study the virus and its host interactions from every angle.

Dr. Michel J. Tremblay, Canada Research Chair in Human Immuno-Retrovirology and Director of the Laboratory of Human Immuno-Retrovirology at Laval University, tackles several approaches in his study of the HIV virus. How the virus incorporates host molecules as it replicates, interactions between the virus and primary target cells (cells of the immune and nervous system), and analysis of gene profiles following viral infection are included within this busy lab’s list of projects.

Cell surface receptors (molecules on the outside of a cell) play a big role in how the HIV virus attaches and gains entry to the host cell. “The identity of novel cell surface receptors involved in the initial interactions between HIV and target cells are of high interest because it can result in design of novel antivirals,” explains Dr. Tremblay. His lab provided the first evidence that DCIR (DC immunoreceptor) acts as an HIV attachment factor, both on immune system T cells and dendritic cells.

Macrophages — host immune cells that gobble up pathogens — are important targets of HIV infection. Because they persist after becoming infected with HIV, they serve as a stable viral reservoir. But macrophages come in many forms and may not all act the same way when it comes to HIV infection. Ultimately their phenotype (polarization status) influences how the virus is consumed (through processes called endocytosis and macropinocytosis). “We reported the overall influence of the polarization process on HIV endocytosis and fate in primary human macrophages. Our results suggest that macropinocytosis is not the sole pathway involved in endocytosis of HIV in macrophages,” explains Dr. Tremblay. This could have important applications to development of antiretrovirals.

The pursuit of knowledge drives Dr. Tremblay to continue his work and he speaks highly of his graduate students “I am very proud of them because they contribute to our society in a positive manner,” says Dr. Tremblay. Always wishing to build talent in his lab, Dr. Tremblay welcomes new and enthusiastic graduate students and postdoctoral fellows.

Dr. Tremblay gives credit to his mentors for setting him on the path of HIV research; “My research interests are directly due to two mentors. I did my doctoral studies under the guidance of Dr. Mark A. Wainberg, who was one of the first Canadian scientists interested in pursuing basic research in HIV/AIDS. Thereafter, I did a postdoctoral fellowship in the laboratory of Dr. Rafick Sékaly.” He is also grateful for the support he’s received from both CIHR and CANFAR over the years “A large portion of our research efforts have been funded by CIHR and CANFAR; they have been essential to my research activities”

The Canadian Association for HIV Research (CAHR), the CIHR HIV/AIDS Research Initiative, the Canadian Foundation for AIDS Research (CANFAR), the CIHR Canadian HIV Trials Network (CTN) and the Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO), thank Dr. Tremblay and his students for their contributions to our understanding of HIV in Canada. Their work is part of a larger Canadian research effort that is making a difference in the lives of those affected by HIV in Canada and around the world.

 

Our Mission

  • Promote excellence in HIV research
  • Foster collaboration and cooperation among HIV research communities, including basic science, clinical science, epidemiology & public health and social science
  • Promote education and the development of new researchers
  • Provide a unified voice for Canadian HIV researchers and engage diverse stakeholders (community, industry, Government, NGO’s etc.) in ongoing dialogue and knowledge exchange to ensure that HIV research remains responsive to their needs

The 30th Annual CAHR Conference on HIV/AIDS will be going virtual, and will be held May 5-7, 2021

Learn More

Recent News

  • La soumission d’abrégés de dernière minute est désormais offerte jusqu’au lundi 15 mars 2021 pour 21 pour # Virtue. Pour en savoir plus et présenter votre abrégé visitez: cahr-acrv.ca/fr/congres/sou…
  • #CAHR2021 Virtual abstract submission for Late Breaker Abstracts is now available until Monday, March 15, 2021. For more information and to submit your abstract see: cahr-acrv.ca/conference/abs…
  • Résultats du concours de bourses de voyage pour professionnels de la santé – 2021
  • 2021 HCP Travel Awards Competition Results
  • The #CAHR2021 Scientific Committee is pleased to announce this year's keynote speakers: Basic Sciences Dr Lynn Morris; Epidemiology and Public Health Sciences Dr Quarraisha Karim Abdool; Clinical Sciences Dr Khalil Ghanem; Social Sciences Ruth Cameron See: cahr-acrv.ca/conference/pro…
  • ACRV 2021 virtuel: Conférenciers annoncés
Subscribe to the CAHR Newsletter

About CAHR

With a membership of more than 1,000 researchers and others interested in HIV research, the Canadian Association for HIV Research (CAHR) is the leading organization of HIV/AIDS researchers in Canada. CAHR is the organizing body for the Annual Canadian Conference on HIV/AIDS Research (CAHR Conference).

CAHR encourages Canadian researchers to be leaders in knowledge translation and to effectively respond both to the Canadian and global HIV/AIDS epidemics. Since its founding in 1991, CAHR has promoted excellence in HIV research, including mentorship and career development of investigators entering the field.

CAHR fosters collaboration and co-operation among HIV research communities, including basic, clinical and social sciences, epidemiology and public health. CAHR also engages people living with HIV/AIDS and AIDS service organizations in ongoing dialogue and information exchange to ensure that HIV/AIDS research remains responsive to the epidemic and its stakeholders.

CAHR is a registered charity.

Links

  • Who We Are
  • Conference
  • Awards
  • Workshops
  • Featured Researchers
  • Student Profiles
  • CAHR News

Contact

For more information or to make a comment, please contact us:

Canadian Association for HIV Research

440 Laurier Avenue West, Suite 200
Ottawa, Ontario K1R 7X6

1-888-374-CAHR (2247)
info@cahr-acrv.ca
  • Media
  • Contact
  • Français